恒瑞医药试验药物竞品情报流程指南 - 起草、审阅、批准和分发
Provide guidance for the drafting, review, approval, and distribution process of competitive intelligence (CI) for the experimental drugs developed by Jiangsu Hengrui Medicine Co., Ltd. (hereinafter referred to as Hengrui), clarify the responsibilities of relevant participants, and ensure that the content of CI meets the needs of users.
原文地址: https://www.cveoy.top/t/topic/lPhd 著作权归作者所有。请勿转载和采集!